<DOC>
	<DOCNO>NCT02528201</DOCNO>
	<brief_summary>A clinical trial ass effect celecoxib 200 milligram ( mg ) daily 400 milligram ( mg ) daily compare diclofenac three time daily treatment Ankylosing Spondylitis ( AS ) 12 week . This used confirm result prior 6 week trial .</brief_summary>
	<brief_title>A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Male female , 18 75 year age , inclusive . Clinical diagnosis ankylose spondylitis : Willing stop exist NSAID/COX2 inhibitor treatment two week . Having give write informed consent participate trial . Pain intensity ≥ 40 mm visual analog scale , worsen least 30 % compare record screen visit . Last administration analgesic without antiinflammatory activity ≥ 8 h , last administration longacting NSAIDs ≥ 72 h Patients acute peripheral articular disease ( defined onset within 4 week prior visit Known inflammatory enteropathy ( e.g . ulcerative colitis , Crohn 's disease ) . Ongoing extraarticular sign ( e.g . cardiac involvement ) . Current painful vertebral compression . Requirement start physiotherapy , reeducation manipulation History clinical gastroduodenal ulcer year precede inclusion , confirm endoscopy ; continue gastrointestinal bleeding . Cardiac failure know renal insufficiency could affect study medication , chronic acute hepatic insufficiency , significant coagulation disorder history asthma . Current history malignancy ( except : patient basal cell carcinoma malignancy operate remission 5 year inclusion trial ) . Pregnancy , woman childbearing potential use adequate contraceptive method nurse mother . Subject evidence alcohol drug abuse . Participation clinical study within 30 day prior screen visit . Any condition would prevent patient enter study , accord investigator 's judgment . Known hypersensitivity celecoxib , sulphonamides NSAID ( include salicylic acid ) . Taking following medication : Muscle relaxant , hypnotic , anxiolytic , sedative , tranquillizer antidepressant ( unless stable 2 week screen continue throughout trial ) , NSAIDs COX2 inhibitor study medication , acetylsalicylic acid ( ASA ) &gt; 160 mg /day , anticoagulant , ticlopidine , lithium , antiTNF agent methotrexate &gt; 15 mg/week ( Note : ASA ≤ 160 mg/day cardioprotection permit ) , Use oral systemic analgesic medication , except paracetamol , within 3 day study entry study , Corticosteroids ( PO/IM/IV/IA ) 6 week precede inclusion trial , Antiulcer medication include chronic ( daily almost daily ) use antacid [ Note : Occasional use antacid study permit . ] Change dose slowacting drug ( e.g . sulfasalazin , methotrexate ) past 60 day precede inclusion trial . Taking paracetamol &gt; 2000 mg/day ( include screen period ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Ankylosing Spondylitis</keyword>
	<keyword>Celecoxib</keyword>
	<keyword>Diclofenac</keyword>
</DOC>